AE
CLBT icon

Axon Enterprise’s Cellebrite CLBT Stock Holding History

Axon Enterprise’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1M Hold
1,310,013
– – 100% 1
2026
Q1 		$18.1M Sell
1,310,013
-199,328
-13% -$3M 100% 1
2025
Q4 		$27.2M Sell
1,509,341
-2,170,034
-59% -$39M 100% 1
2025
Q3 		$68.2M Sell
3,679,375
-5,320,625
-59% -$83.6M 100% 1
2025
Q2 		$144M Hold
9,000,000
– – 100% 1
2025
Q1 		$175M Hold
9,000,000
– – 100% 1
2024
Q4 		$198M Buy
+9,000,000
New +$173M 100% 1

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Axon Enterprise's CLBT Position: Q2 2026 in Review

Axon Enterprise held its Cellebrite (CLBT) position steady in Q2 2026 at 1,310,013 shares worth $19.1M. The position accounts for 100% of the portfolio, ranked #1.

Axon Enterprise first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $198M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Axon Enterprise held 1,310,013 shares of Cellebrite worth $19.1M as of Q2 2026.
  • Axon Enterprise left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up 100% of Axon Enterprise's portfolio in Q2 2026, its #1 holding.
  • Axon Enterprise first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
  • Axon Enterprise's Cellebrite position peaked at $198M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Axon Enterprise's 13F filing for Q2 2026, filed 14 Aug 2026.